Cigna Group Reports Strong Q4 & FY25 Results, Raises 2026 Outlook, and Increases Dividend
CI is trading near its 52-week low of $239.51 (13% above the low) on elevated volume (2.3× avg).
Summary
The Cigna Group announced robust fourth quarter and full year 2025 financial results, provided an optimistic 2026 outlook with increased adjusted EPS guidance, and raised its quarterly dividend, signaling strong operational performance and commitment to shareholder returns.
Key Events · Earnings and Guidance · CI
-
Strong Q4 and FY2025 Financial Performance
Total revenues for 2025 increased 11% to $274.9 billion, with adjusted income from operations rising to $8.0 billion, or $29.84 per share. Fourth quarter adjusted income from operations also saw a 16% increase.
-
Positive 2026 Financial Outlook
The company projects 2026 adjusted revenues of approximately $280.0 billion and adjusted income from operations of at least $7.950 billion, or $30.25 per share, indicating continued growth.
-
Quarterly Dividend Increase
The Board of Directors declared an increase in the quarterly cash dividend to $1.56 per share, up from $1.51 per share, reflecting confidence in future earnings.
-
Significant Share Repurchase Program
In 2025, Cigna Group repurchased 11.9 million shares of common stock for approximately $3.6 billion, representing a substantial return of capital to shareholders.
Analysis · CI · Finance
The Cigna Group's latest 8-K filing reveals a strong financial position and a positive trajectory for the coming year. The company reported robust revenue growth and increased adjusted income from operations for both the fourth quarter and full year 2025, driven by strong performance in Evernorth Health Services and Cigna Healthcare (excluding divestitures). The optimistic 2026 outlook, with projected increases in adjusted revenues and EPS, suggests management's confidence in sustained operational momentum. Furthermore, the significant $3.6 billion share repurchase program in 2025, coupled with an increased quarterly dividend, underscores a strong commitment to enhancing shareholder value and returning capital. The improvement in the debt-to-capitalization ratio also highlights prudent financial management. Investors should view these announcements as a strong signal of the company's health and future prospects.
At the time of this filing, CI was trading at $271.00 on NYSE in the Finance sector, with a market capitalization of approximately $72.6B. The 52-week trading range was $239.51 to $350.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.